PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFludrocortisone acetate
Fludrocortisone acetate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
69 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Septic shockD012772A48.33417
HypotensionD007022EFO_0005251I95221137
Orthostatic hypotensionD007024I95.1111136
Adrenal insufficiencyD000309325
Vasovagal syncopeD019462R551135
SyncopeD013575G90.011135
SepsisD018805EFO_0001420A41.91113
Systemic inflammatory response syndromeD018746EFO_1001478R65.1011
HypertensionD006973EFO_0000537I1011
HypersensitivityD006967EFO_0003785T78.4011
Show 1 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C6182210
Castration-resistant prostatic neoplasmsD0641295216
Congenital adrenal hyperplasiaD000312E25.011114
Critical illnessD016638112
ShockD012769R57.1112
Cardiogenic shockD012770R57.011
Wounds and injuriesD014947T14.811
Traumatic brain injuriesD000070642S0611
Craniocerebral traumaD006259S0011
PneumoniaD011014EFO_0003106J1811
Show 7 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients516
Subarachnoid hemorrhageD013345EFO_0000713I60112
Parkinson diseaseD010300EFO_0002508G20112
MelanomaD00854511
Renin-angiotensin systemD012084111
Ovarian hyperstimulation syndromeD01647111
SyndromeD01357711
Heart failureD006333EFO_0003144I50111
NeoplasmsD009369C8011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863F33.9112
Hearing lossD034381EFO_0004238H91.911
Sensorineural hearing lossD006319H90.511
DeafnessD003638EFO_0001063H91.911
Pharmacological phenomenaD00006943711
Shy-drager syndromeD012791EFO_100105011
Multiple system atrophyD01957811
AtrophyD00128411
AdenocarcinomaD00023011
Chronic kidney failureD007676EFO_0003884N18.611
Show 1 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Major depressive disorderD003865EFO_0003761F2222
Type 1 diabetes mellitusD003922EFO_0001359E1011
Pure autonomic failureD05497011
HypoglycemiaD007003E16.211
Depressive disorderD003866EFO_1002014F32.A11
HemorrhageD006470MP_0001914R5811
Inappropriate adh syndromeD007177EFO_1000982E22.211
HyponatremiaD007010E87.111
Wasting syndromeD01928211
CachexiaD002100R6411
Show 15 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 410 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
297 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use